http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5726866

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article
endingPage 463
issn 0277-3732
issueIdentifier 5
pageRange 460-463
publicationName American Journal of Clinical Oncology
startingPage 460
bibliographicCitation Stein ME, Bernstein Z, Tsalic M, Drumea K, Steiner M, Sklar Z, Haim N. Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study. Am J Clin Oncol. 2002 Oct;25(5):460–3. doi: 10.1097/00000421-200210000-00007. PMID: 12393984.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24c11bc3ca4a87842471f2018042cac1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_828e8d60ab0408142bd9f1c3a815e3d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5022c8ebd0f9c9040c90d684b8215f0c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3856e18453048ddc5ac14074372105e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dad4552f854fd758501d2d946f32f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f75e96ab97f9375f3c8c4a1cd26aa0ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ba1ee51588730a7c5104f6fe2c19f79
date 200210
identifier https://doi.org/10.1097/00000421-200210000-00007
https://pubmed.ncbi.nlm.nih.gov/12393984
isPartOf https://portal.issn.org/resource/ISSN/0277-3732
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/413
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study
discusses http://id.nlm.nih.gov/mesh/M0025711
http://id.nlm.nih.gov/mesh/M0552528
http://id.nlm.nih.gov/mesh/M0021024
http://id.nlm.nih.gov/mesh/M0004505
http://id.nlm.nih.gov/mesh/M0003490
http://id.nlm.nih.gov/mesh/M0018641
http://id.nlm.nih.gov/mesh/M0005636
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D008545Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D002330Q000008
http://id.nlm.nih.gov/mesh/D008545Q000556
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D016898Q000008
http://id.nlm.nih.gov/mesh/D013629Q000008
http://id.nlm.nih.gov/mesh/D011994
http://id.nlm.nih.gov/mesh/D002945Q000008
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D000077190
http://id.nlm.nih.gov/mesh/D012074
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D003606Q000008
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53786765
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127750960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789476

Total number of triples: 67.